Mirum Pharmaceuticals (MIRM) Competitors $52.02 +0.34 (+0.66%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$52.01 -0.01 (-0.02%) As of 08/1/2025 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM vs. VRNA, BBIO, BPMC, ROIV, LEGN, ELAN, RGC, RVMD, GRFS, and TGTXShould you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Verona Pharma PLC American Depositary Share (VRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Regencell Bioscience (RGC), Revolution Medicines (RVMD), Grifols (GRFS), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Mirum Pharmaceuticals vs. Its Competitors Verona Pharma PLC American Depositary Share BridgeBio Pharma Blueprint Medicines Roivant Sciences Legend Biotech Elanco Animal Health Regencell Bioscience Revolution Medicines Grifols TG Therapeutics Mirum Pharmaceuticals (NASDAQ:MIRM) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk. Do insiders & institutionals believe in MIRM or VRNA? 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 14.4% of Mirum Pharmaceuticals shares are owned by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is MIRM or VRNA more profitable? Verona Pharma PLC American Depositary Share has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -20.39%. Mirum Pharmaceuticals' return on equity of -33.63% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets Mirum Pharmaceuticals-20.39% -33.63% -11.50% Verona Pharma PLC American Depositary Share N/A -69.65%-28.00% Which has more volatility & risk, MIRM or VRNA? Mirum Pharmaceuticals has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Which has stronger valuation & earnings, MIRM or VRNA? Mirum Pharmaceuticals has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than Mirum Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMirum Pharmaceuticals$336.89M7.65-$87.94M-$1.61-32.31Verona Pharma PLC American Depositary Share$42.28M211.78-$173.42M-$2.00-52.59 Does the media favor MIRM or VRNA? In the previous week, Verona Pharma PLC American Depositary Share had 6 more articles in the media than Mirum Pharmaceuticals. MarketBeat recorded 11 mentions for Verona Pharma PLC American Depositary Share and 5 mentions for Mirum Pharmaceuticals. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.22 beat Mirum Pharmaceuticals' score of 1.10 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mirum Pharmaceuticals 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verona Pharma PLC American Depositary Share 8 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend MIRM or VRNA? Mirum Pharmaceuticals currently has a consensus target price of $65.50, indicating a potential upside of 25.91%. Verona Pharma PLC American Depositary Share has a consensus target price of $109.00, indicating a potential upside of 3.63%. Given Mirum Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Mirum Pharmaceuticals is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15 SummaryMirum Pharmaceuticals beats Verona Pharma PLC American Depositary Share on 12 of the 17 factors compared between the two stocks. Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRM vs. The Competition Export to ExcelMetricMirum PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.56B$3.00B$5.48B$9.51BDividend YieldN/A2.43%4.73%4.08%P/E Ratio-32.3117.6228.6723.80Price / Sales7.65179.18373.9066.65Price / CashN/A41.9535.4557.96Price / Book11.078.508.275.55Net Income-$87.94M-$55.06M$3.24B$259.03M7 Day Performance0.37%-3.98%-3.69%-4.59%1 Month Performance5.97%9.59%4.33%4.46%1 Year Performance32.10%6.72%25.95%18.03% Mirum Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRMMirum Pharmaceuticals3.7376 of 5 stars$52.02+0.7%$65.50+25.9%+29.6%$2.56B$336.89M-32.31140News CoveragePositive NewsUpcoming EarningsVRNAVerona Pharma PLC American Depositary Share2.1954 of 5 stars$104.90flat$109.00+3.9%+365.2%$8.93B$42.28M-52.4530Positive NewsUpcoming EarningsShort Interest ↑BBIOBridgeBio Pharma4.7123 of 5 stars$45.90-1.3%$61.50+34.0%+80.9%$8.83B$221.90M-13.00400Upcoming EarningsAnalyst ForecastBPMCBlueprint Medicines1.0661 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640Upcoming EarningsROIVRoivant Sciences1.8472 of 5 stars$11.48+0.3%$16.50+43.7%+6.5%$7.78B$29.05M0.00860Upcoming EarningsLEGNLegend Biotech3.5917 of 5 stars$42.23+1.5%$73.33+73.7%-29.5%$7.64B$627.24M-71.582,609Positive NewsELANElanco Animal Health3.8056 of 5 stars$14.67-0.8%$16.00+9.1%+5.9%$7.34B$4.44B19.829,000Positive NewsUpcoming EarningsRGCRegencell Bioscience0.0502 of 5 stars$14.40-0.7%N/AN/A$7.17BN/A0.0010Positive NewsRVMDRevolution Medicines4.467 of 5 stars$38.42+0.3%$68.91+79.4%-19.1%$7.13B$11.58M-9.61250News CoveragePositive NewsUpcoming EarningsGRFSGrifols3.1017 of 5 stars$10.00+0.6%$10.30+3.0%+41.1%$6.83B$7.81B8.5523,822Dividend AnnouncementTGTXTG Therapeutics4.0843 of 5 stars$37.42-1.3%$43.80+17.0%+85.0%$6.02B$329M157.96290Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share Competitors BridgeBio Pharma Competitors Blueprint Medicines Competitors Roivant Sciences Competitors Legend Biotech Competitors Elanco Animal Health Competitors Regencell Bioscience Competitors Revolution Medicines Competitors Grifols Competitors TG Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
